Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment

被引:1
|
作者
Firnhaber, Jonathon M. [1 ]
机构
[1] East Carolina Univ, Brody Sch Med, Greenville, NC 27834 USA
关键词
PRIMARY-CARE; SKIN; MANAGEMENT; RISK;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Keratinocyte carcinoma, traditionally referred to as nonmelanoma skin cancer, includes basal cell and cutaneous squamous cell carcinoma and is the most common skin cancer malignancy found in humans. The U.S. Preventive Services Task Force recommends counseling about minimizing exposure to ultraviolet radiation for people aged six months to 24 years with fair skin types to decrease their risk of skin cancer. Routine screening for skin cancer is controversial. The U.S. Preventive Services Task Force concludes that current evidence is insufficient to assess the balance of benefits and harms of a routine whole-body skin examination to screen for skin cancer. Basal cell carcinoma commonly appears as a shiny, pearly papule with a smooth surface, rolled borders, and arborizing telangiectatic surface vessels. Cutaneous squamous cell carcinoma commonly appears as a firm, smooth, or hyperkeratotic papule or plaque, and may have central ulceration. Initial tissue sampling for diagnosis is a shave technique if the lesion is raised, or a punch biopsy of the most abnormal-appearing area of skin. High-risk factors for recurrence and metastasis include prior tumors, ill-defined borders, aggressive histologic patterns, and perineural invasion. Mohs micrographic surgery has the lowest recurrence rate among treatments but is best considered for large, high-risk tumors or tumors in sensitive anatomic locations. Smaller, lower-risk tumors are treated with surgical excision, electrodesiccation and curettage, or cryotherapy. Topical imiquimod and fluorouracil are also treatment options for superficial basal cell carcinoma and squamous cell carcinoma in situ. There are no clear guidelines for follow up after an index keratinocyte carcinoma, but monitoring for recurrence is important because the five-year risk of subsequent skin cancer is 41%. After more than one diagnosis, the five-year risk increases to 82%. Copyright (C) 2020 American Academy of Family Physicians.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
  • [31] Giant squamous cell carcinomas of the shoulder
    Yahyaoui, Mounir
    Abbassi, Najib
    Derfoufi, Abdelhafid
    Daoudi, Abdelkarim
    Agoumi, Omar
    Yacoubi, Hicham
    Najib, Abdeljaouad
    Serji, Badr
    Elharroudi, Tijjani
    Mouzouri, Nabil
    Dikhaye, Siham
    Zizi, Nada
    Hadjkacem, Hanane
    PAN AFRICAN MEDICAL JOURNAL, 2020, 36 : 1 - 6
  • [32] The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas
    Alonso-Juarranz, Miguel
    Mascaraque, Marta
    Carrasco, Elisa
    Gracia-Cazana, Tamara
    De La Sen, Oscar
    Gilaberte, Yolanda
    Gonzalez, Salvador
    Juarranz, Angeles
    Falahat, Farzin
    CANCERS, 2023, 15 (12)
  • [33] Sirolimus Reduces Cutaneous Squamous Cell Carcinomas in Transplantation Recipients Reply
    de Fijter, Johan W.
    Bavinck, Jan Nico Bouwes
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) : 3298 - 3298
  • [34] Cutaneous and lip squamous cell carcinomas in an albinism patient: A case report
    Siauta, Jan Frits
    Windura, Carolus Aldo
    Putra, Louis Kartono
    ANNALS OF MEDICINE AND SURGERY, 2022, 81
  • [35] Cutaneous Basal Cell Carcinoma with Dual Differentiation into Squamous Cell Carcinoma and Spindle Cell Squamous Cell Carcinoma: A Case Report with Immunohistochemical Studies
    Terada, Tadashi
    DERMATOLOGIC SURGERY, 2013, 39 (01) : 130 - 132
  • [36] Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma
    Mohan, Shalini V.
    Chang, Julia
    Li, Shufeng
    Henry, A. Solomon
    Wood, Douglas J.
    Chang, Anne Lynn S.
    JAMA DERMATOLOGY, 2016, 152 (05) : 527 - 532
  • [37] Evaluation of the 'Hedgehog' signaling pathways in squamous and basal cell carcinomas of the eyelids and conjunctiva
    Celebi, Ali Riza Cenk
    Kiratli, Hayyam
    Soylemezoglu, Figen
    ONCOLOGY LETTERS, 2016, 12 (01) : 467 - 472
  • [38] Lower lip basal cell and squamous cell carcinomas: a reappraisal of the similarities and differences in clinical presentation and management
    Hwang, Jacqueline R.
    Khachemoune, Amor
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (02) : 117 - 125
  • [39] Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas
    Wang, X. -Y.
    Zhang, R.
    Lian, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (01) : 69 - 76
  • [40] Utilizing fractional lasers and tirbanibulin ointment to treat squamous and basal cell carcinomas
    Robinson, Bruce P.
    Nanni, Gillian M.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (10)